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Abstract
Purpose of review—The musculoskeletal system is largely regulated through dynamic physical 
activity and is compromised by cessation of physical loading. There is a need to recreate the 
anabolic effects of loading on the musculoskeletal system, especially in frail individuals who 
cannot exercise. Vibration therapy is designed to be a nonpharmacological analogue of physical 
activity, with an intention to promote bone and muscle strength.
Recent findings—Animal and human studies suggest that high-frequency, low-magnitude 
vibration therapy improves bone strength by increasing bone formation and decreasing bone 
resorption. There is also evidence that vibration therapy is useful in treating sarcopenia, which 
confounds skeletal fragility and fall risk in aging. Enhancement of skeletal and muscle strength 
involves regulating the differentiation of mesenchymal stem cells to build these tissues; 
mesenchymal stem cell lineage allocation is positively promoted by vibration signals.
Summary—Vibration therapy may be useful as a primary treatment as well as an adjunct to both 
physical and pharmacological treatments, but future studies must pay close attention to 
compliance and dosing patterns, and importantly, the vibration signal, be it low-intensity vibration 
(<1g) appropriate for treatment of frail individuals or high-intensity vibration (>1g) marketed as a 
training exercise.
Keywords
low-intensity vibration; mesenchymal stem cells; osteocyte; osteoporosis
INTRODUCTION
Conditions associated with reduced mobility and systemic decline lead to failure of the 
musculoskeletal system with loss of skeletal strength and muscle dysfunction, significantly 
compromising measures of life quality. Both bone and muscle perceive and respond to local 
dynamic loading, building form, and strength to support function [1]. The need to 
mechanically load the skeleton translates to ‘use it or lose it’. As such, pathological or 
occupational reductions in functional loading manifest as bone becomes more susceptible to 
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fracture [2]. To avoid off-target pharmacological complications, it makes more sense to 
physically target the musculoskeletal system: mechanical signals present unique advantages 
in that effects are both self-targeting and self-optimizing. However, typical exercise 
regimens (running or walking) are difficult for frail individuals. Vibration therapy delivered 
as a low-magnitude, high-frequency stimulus [‘LIV’ defined as <1 gravity (g =acceleration 
of 9.81 m/s2, frequency >30 Hz)] offers a means to deliver relevant mechanical signals 
safely to patients who can not exercise to build musculoskeletal strength [3]. Low intensity 
vibration (LIV), as compared with devices that deliver high-magnitude signals (>1g), 
provides different levels of applicability and safety.
What types of mechanical signals does the skeleton perceive as anabolic? Bone formation 
requires dynamic mechanical loading, with varied time between loading bouts [4]. In 
contrast, static loads induce bone resorption [5]. Dynamic load has both magnitude and 
frequency components within the bone matrix [6]. Large-magnitude strain can induce tissue 
responses directly via matrix deformation or indirectly through fluid shear, pressure, or 
streaming potentials [7]. The skeleton experiences relatively few low-frequency (1–3 Hz), 
large-magnitude (2000–3000 microstrain) events throughout the day but is bombarded with 
persistent high-frequency (10–50 Hz), low-magnitude signals [8]. These constant small 
signals are generated from postural muscle contractions; these contractions decrease with 
sarcopenia or disuse muscle atrophy [9]. LIV therapy replicates these high-frequency, low-
magnitude signals to improve bone strength [10].
Vibration therapy is directed at processes activated by direct mechanical loading [7] (Fig. 1), 
including the progenitor for osteoblasts, osteocytes, and myocytes, the mesenchymal stem 
cell (MSC). Vibration directs osteogenic differentiation [11] while restricting MSC 
adipogenic commitment [12]. Although little is known regarding effects of vibration on 
osteocytes embedded in mineralized tissue, vibration of osteocytes in culture decreased 
expression of osteoclast-forming RANKL [13], which rises during unloading [14], and 
increased cell communication [15■]. Also, the hematopoietic-derived osteoclast is 
mechanically responsive [16] and vibration reduced osteoclast formation [17].
Anabolic effects of low-intensity mechanical signals on bone may be induced indirectly via 
extra-skeletal tissues. Enhanced muscle strength, size, and performance were observed in 
humans [18] and animals [19] following vibration, possibly due to increased neuromuscular 
efficiency [18]. Vibration enhances expression of anabolic genes in tendons [20]. Other 
studies suggest that bone density increases due to vibration’s repression of fat development 
[12,21]. The molecular mechanisms controlling these responses may be due to enhanced β-
catenin [12] or enhanced gap junction communication [15■]. Signal activation may be 
induced via acceleration of the cell nucleus [15■], independently of matrix strain [12] or 
fluid shear [22,23].
HUMAN STUDIES
Whole-body vibration (WBV) is a promising non-pharmacological treatment strategy to 
improve bone quality, strength, and posture in patients who are unable to perform high-
impact exercises (Fig. 2). Available human trials are complicated because of multiple 
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vibration parameters ranging from high (3–5g) to low intensity (<1g). Although high-
intensity vibration devices are frequently found in gyms and marketed as workout machines, 
it is unsuited for frail patients. WBV regimens need to be optimized for anabolic responses 
while minimizing adverse effects.
A double-placebo controlled study evaluated the effects of low-intensity WBV on bone 
density in humans; postmenopausal women were randomized to receive 2 × 10 min LIV 
(0.2g, 30 Hz) or an inactive placebo plate [24]. Women with high adherence showed a 
benefit of LIV: the control group lost 2% femoral neck bone mineral density (BMD) 
whereas the treatment group gained 0.04%, a 2.17% relative BMD increase. Similar LIV 
signals were studied over 1 year in premenopausal women with low Z-scores and positive 
fracture history [25]. Quantitative computed tomography showed that women in the active 
LIV group gained 2% trabecular and cortical bone compared with the inactive group. 
Imaging also showed LIV caused a 4.9% increase in paraspinous muscle area.
Several subsequent studies confirmed improvement in BMD with WBV; however, these 
studies are of varying quality and design. In some cases, high-intensity vibration was used 
and was linked to back and joint pain. A nonrandomized controlled study of 116 
postmenopausal women with osteoporosis who received high-intensity vibration (30 Hz, 5 
mm amplitude =18g) for 10 min 5 days a week increased lumbar and femoral neck BMD by 
4.3 and 3.2%, respectively [26]. Another high-magnitude 30 Hz, 3.2g study dosed for 5 min 
thrice weekly showed a 2% significant increase in lumbar spine BMD in postmenopausal 
women in which controls lost bone over 6 months [27].
More recently, in a randomized controlled trial [28], 202 osteopenic postmenopausal women 
were randomized to LIV (0.3g, 37 or 90 Hz) for 20 min daily for 1 year. No significant 
differences were found in the primary outcome of tibial trabecular volumetric BMD or in 
secondary measures such as femoral neck, total hip, or lumbar spine BMD [28]. However, 
compliance with LIV of 65–79% was poor. Limitations included low adherence, lack of 
very low bone density, and the fact that the placebo group did not lose significant bone 
density over the year study.
Several studies evaluated the ability of WBV to augment the anabolic effects of dynamic 
exercise. Gomez-Cabello et al. [29] randomized 49 elderly men and women to receive either 
WBV (35 Hz, ~16g) while completing a trained squat three times a week for 11 weeks or to 
a control group receiving no vibration or exercise. At the end of the short study, there were 
no changes in dual-energy X-ray absorptiometry scan measures. An 18-month study showed 
that vibration therapy combined with low-impact activity enhanced the effect of training to 
increase lumbar BMD [30]. Interestingly, the vibration group had decreased falls as well. 
Another recent study [31] in seniors combined 6-month vibration therapy (44–55 Hz, 0.5g) 
with a tilting angle exercise for 20 min thrice weekly demonstrated LIV-induced BMD 
increases that were higher in women compared with men, and in participants with 
osteoporosis, compared with those without low bone density.
The effects of LIV have been studied in children with immobility-associated disability. 
Children with disabling conditions randomized to LIV (90 Hz, 0.3g, 10 min/day) 
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demonstrated a 6.3% increase, whereas those in the control group had a decrease of 12% in 
BMD [32]. In children with osteogenesis imperfecta, high-intensity vibration (15–20 Hz, 1–
2 mm amplitude, ~12g) combined with tilt-table exercise induced improvements in muscle 
and ground reaction forces [33]. Children with idiopathic scoliosis may also benefit: 149 
girls, 15–25 years old with adolescent idiopathic scoliosis with Z-scores below −1, were 
randomized to low-magnitude, high-frequency WBV (32–37 Hz, 0.3g) for 20 min/day, 5 
days weekly for 12 months [34]. The treatment group showed significant increases in 
femoral neck BMD from baseline (0.015–2.15g/cm2) and an increase in lumbar spine bone 
compared with controls. These studies suggest that vibration has greater anabolic potential 
in the growing skeleton, perhaps by altering the outcome of a more robust MSC pool.
The Gilsanz et al. study [25] reviewed above suggested that muscles in young females 
responded to LIV. In a post-hoc analysis of girls who used LIV for at least 2 min daily, an 
even higher influence on muscle and bone formation was seen. Even in postmenopausal 
women, LIV enhanced effects of a squat/lunge resistance training program; simultaneous 
treatment with LIV (35–40 Hz, 2–5g) induced 15% increases in knee strength [35]. Other 
studies support that WBV has the potential to increase effects of exercise training. Four 
months of high-intensity vibration (30–40 Hz, 2–2.8g) combined with resistance exercises in 
postmenopausal women enhanced muscular strength compared with resistance training 
alone at multiple sites [36]. Further, WBV training combined with exercise improved 
strength and balance in stroke patients. After 6 weeks, patients receiving WBV (35–40 Hz, 
1.7–2.5 mm, ~16g) for 30–60 s, thrice weekly had significant improvements in lower limb 
strength and postural control compared with non-LIV individuals [37■]. At this point, 
however, we would caution that there is no evidence that high-intensity vibration performs 
better than low-intensity vibration, and may lead to adverse effects.
LIV may also be beneficial for postural instability due to sarcopenia or degraded 
neuromuscular control due to immobility [38]. LIV (39 Hz, 0.3–0.5g) was studied in healthy 
adults subjected to 90 days of head-down tilt bed rest. Postural stability, measured by 
plantar-based center displacement and velocity, showed LIV treatment defended against a 
loss of stability due to bed rest. Overall, LIV may limit musculoskeletal degeneration caused 
by physical inactivity, which leads to falls and fracture.
ANIMAL STUDIES
Animal studies proved the efficacy of LIV on bone endpoints by avoiding human study 
limitations of age, sex, hormonal status, and comorbidity. For instance, adult sheep exposed 
to daily LIV (30 Hz, 0.3g, 20 min) showed a 34% increase in femoral trabecular bone by 
micro-computed tomography and histology at 1 year [39,40]. In mice, only 3 weeks of LIV 
increased trabecular bone, with a greater response to the 0.3g, rather than 0.6g, parameter 
[41].
Interestingly, genetic variation within mice also modulates the sensitivity of the skeleton to 
mechanical stimuli. Mouse strains display varying responses to anabolic LIV treatment and 
the catabolic effects of disuse (unloading). In the ‘low density’ C57BL/6J mouse, hind limb 
unloading did not affect bone formation rate (BFR), and LIV induced significant increases 
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in the BFR of both loaded and unloaded hind limbs. Unloading in the ’mid-density’ BALB/
cByJ mouse significantly reduced BFR and this was ameliorated by LIV. Finally, the ‘high-
density’ C3H/HeJ mice did not respond to either disuse or LIV [42]. This suggests that 
genetics influence the skeletal response to physical cues and may partially explain why 
vibration is not universally effective in humans.
Can LIV prevent estrogen deficiency bone loss? Treatment with LIV for 28 days following 
ovariectomy in mature rats led to a 159% increase in trabecular bone formation [6]. Further, 
in ovariectomized rat bone, LIV not only increased periosteal BFR but also decreased 
endocortical resorption, resulting in improved biomechanical strength [43].
Animal studies reinforce that specific genetic mutations leading to skeletal fragility also 
might be amenable to vibration therapy. The severe bone fragility of osteogenesis imperfecta 
is associated with overactive bone remodeling with disorganized woven bone, reduced 
BMD, and decreased mechanical properties [44]. Some improvements in skeletal endpoints 
have been achieved with bisphosphonates [45], but long-term therapy is concerning in 
growing children [46]. An osteogenesis imperfecta mouse model provides promising results 
for the use of vibration to improve bone properties. LIV treatment (0.3g, 45 Hz, 15 min, 5 
day/week) resulted in significantly improved femoral and tibial cortical area and thickness 
compared with sham controls after 5 weeks, with improved trends in trabecular bone 
[47■■].
Vibration therapy may also be an effective adjunct to pharmacological interventions aimed 
at improving low bone mass. A recent study compared alendronate treatment in combination 
with LIV (0.3g, 45–55 Hz, 20 min/day, five times/week). After 3 months, alendronate alone 
induced greater improvements in trabecular bone compared with LIV alone; however, 
combining alendronate and LIV resulted in the greatest anabolic response [48■■]. This 
study demonstrates the potential for LIV to augment drug treatments targeting bone.
Fracture healing may also be improved by LIV. Individuals with low bone density or poor 
bone quality resulting from hormonal imbalances or genetic mutations have higher risk for 
fracture [49]. Bone fractures, especially in the elderly, lead to severe functional and 
economic burdens [50]. LIV can be delivered to bed-bound patients, at risk for fracture 
disunion, as it is well known that loading is critical to achieving successful fracture 
remodeling. Fracture repair was studied in ovariectomy (OVX) rats: LIV (35–90 Hz, 15 
min/daily) resulting in improved callus density, enlarged callus area and width, accelerated 
osteotomy bridging, upregulated osteocalcin expression, and suppressed osteoclast activity 
at 30 days [51]. Another OVX rat tibial osteotomy fracture model combined LIV with either 
estrogen or raloxifene treatment; combination therapy with LIV and estrogens resulted in 
improved stiffness and increased endosteal and trabecular bone densities compared with LIV 
or raloxifene alone [52]. These studies suggest that LIV can enhance current 
pharmacological interventions for fracture healing.
DEVICES
A significant problem with the scientific literature of vibration therapy, as well as 
practitioner and patient comprehension, is the availability of multiple devices from which 
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clinical information has been collected. These devices deliver different directionality 
(horizontal displacement from side-to-side or vertically), amplitudes (displacements 
resulting in gravitational force from less than 1 to greater than 15g), and frequency (5–90 
Hz) [53] (Fig. 3). Some high-intensity devices are marketed as workout or slimming 
devices, and can increase muscle damage and even generate unwanted rotational movements 
in joints, which buffer impacts of loading [54]. In contrast, low-intensity vertical vibration 
devices are well tolerated [32,34].
A Google search brings up more than 50 devices that deliver WBV. Most of these provide 
information regarding displacement and frequency. Importantly, the key index of safety 
(determined by occupational safety and health administration) is acceleration, or g-force. g-
force is derived from a complex product of displacement and frequency (for example, 
displacing 1 mm at 10 Hz results in 0.4g, but increasing frequency to 50 Hz results in 10g 
acceleration). Most vibration devices can provide both high-magnitude (>1g) and low-
magnitude (<1g) forces, but those marketed as workout adjuncts generally deliver forces 
greater than 4g. Such exercise devices are not appropriate for elderly or frail patients in 
whom the endpoint is improving bone strength [55]. When selecting a treatment regimen, 
we would recommend that physicians and rehabilitation specialists use devices that clearly 
report the vibration parameters and that deliver low-intensity (<1g), horizontal 
displacements at high frequencies (30–100 Hz).
CONCLUSION
Skeletal disuse leads to a wide array of consequences in the musculoskeletal system. 
Providing noninvasive, anabolic mechanical signals to mimic exercise in bone presents an 
attractive alternative to pharmacological treatments for osteoporosis. Although drug 
interventions have relied almost exclusively on preventing bone resorption, low-intensity 
vibration initiates anabolic responses and counteracts catabolic signals. Furthermore, the 
musculoskeletal system’s self-targeting response to mechanical signals avoids off-target 
effects and bestows additional benefits, including improved postural control and 
neuromuscular activation. These positive influences are at least partly conveyed through 
mechanical regulation of mesenchymal stem cells, which provide progenitors for bone and 
muscle growth. Although a uniform consensus regarding the most effective anabolic 
treatment regimen has not been reached, delivering low-magnitude mechanical signals is an 
appealing method to supply an exercise surrogate for those who are otherwise unable to load 
their skeletons.
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• Low-intensity, high-frequency vibration therapy is a promising exercise 
analogue to stimulate anabolic responses of the musculoskeletal system.
• Until it is clear that the benefits of high-intensity vibration outweigh its adverse 
effect consequences, physicians and other healthcare providers should consider 
low-intensity (<1g) treatments for their patients.
• Additional studies are needed to identify the most effective intensity, frequency, 
and duration of the vibration treatments and to investigate its use to enhance 
other physical/exercise and pharmacological therapies.
• Vibration therapy may cause a more pronounced anabolic effect in children, 
possibly due to stimulation of osteogenesis from the increased pool of 
mesenchymal progenitor cells in younger individuals.
• Low-intensity vibration therapy likely targets multiple tissues within the 
neuromuscular and musculoskeletal systems, leading to an additive anabolic 
effect, thus improving overall musculoskeletal health.
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Cellular targets of vibration. The physiological effects of vibration are mediated by 
individual cellular actions. Low-magnitude mechanical signals target many cell types 
including mesenchymal stem cells, osteoblasts, osteocytes, adipocytes, osteoclasts, 
myocytes, and neurons.
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Physiological responses of whole-body vibration. Delivery of low-magnitude mechanical 
signals mimic aspects of loading exercise, providing direct benefits to the skeleton, but also 
indirectly improves musculoskeletal outcomes including balance, posture, and muscle 
strength. These additional benefits feed back to further enhance skeletal strength.
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Vibration dynamics. Displacement (amplitude) of the vibration plate, which when combined 
with the sinusoidal period duration (frequency, Hz) can be translated into acceleration (g-
force). Vibration can be dosed horizontally with acceleration directed upward through the 
hips, or in side-to-side alternating vibrations in which forces are buffered by joints.
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